双甲磺酸钠改善肝肺综合征的氧合作用

François Milhe , Martine Reynaud-Gaubert , Antoine Magnan , Stéphane Delpierre , Daniel Vervloet
{"title":"双甲磺酸钠改善肝肺综合征的氧合作用","authors":"François Milhe ,&nbsp;Martine Reynaud-Gaubert ,&nbsp;Antoine Magnan ,&nbsp;Stéphane Delpierre ,&nbsp;Daniel Vervloet","doi":"10.1016/j.rmedx.2006.03.004","DOIUrl":null,"url":null,"abstract":"<div><p>A 51 years old male patient was referred for dyspnoea on minimal exertion associated with a severe hypoxemia (<em>P</em>aO<sub>2</sub>=66<!--> <!-->mmHg) and respiratory alkalosis. Investigations led to the diagnosis of hepatopulmonary syndrome. <em>P</em>aO<sub>2</sub> increased from 60 to 75<!--> <!-->mmHg after one hour of i.v. almitrine bismesylate infusion, and it remained at 85<!--> <!-->mmHg after 3 months of further per os treatment. This case of hepatopulmonary syndrome is the first to be persistently improved by almitrine bismesylate. Increase of <em>P</em>aO<sub>2</sub> would at least delay the hepatic transplantation.</p></div>","PeriodicalId":101082,"journal":{"name":"Respiratory Medicine Extra","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rmedx.2006.03.004","citationCount":"7","resultStr":"{\"title\":\"Oxygenation improvement with almitrine bismesylate in the hepatopulmonary syndrome\",\"authors\":\"François Milhe ,&nbsp;Martine Reynaud-Gaubert ,&nbsp;Antoine Magnan ,&nbsp;Stéphane Delpierre ,&nbsp;Daniel Vervloet\",\"doi\":\"10.1016/j.rmedx.2006.03.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>A 51 years old male patient was referred for dyspnoea on minimal exertion associated with a severe hypoxemia (<em>P</em>aO<sub>2</sub>=66<!--> <!-->mmHg) and respiratory alkalosis. Investigations led to the diagnosis of hepatopulmonary syndrome. <em>P</em>aO<sub>2</sub> increased from 60 to 75<!--> <!-->mmHg after one hour of i.v. almitrine bismesylate infusion, and it remained at 85<!--> <!-->mmHg after 3 months of further per os treatment. This case of hepatopulmonary syndrome is the first to be persistently improved by almitrine bismesylate. Increase of <em>P</em>aO<sub>2</sub> would at least delay the hepatic transplantation.</p></div>\",\"PeriodicalId\":101082,\"journal\":{\"name\":\"Respiratory Medicine Extra\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2006-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.rmedx.2006.03.004\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Respiratory Medicine Extra\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1744904906000117\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory Medicine Extra","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1744904906000117","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

摘要

一位51岁男性患者因呼吸困难而入院,并伴有严重低氧血症(PaO2=66 mmHg)和呼吸性碱中毒。经检查诊断为肝肺综合征。静脉滴注双甲磺酸阿米特林1小时后,PaO2从60 mmHg升高至75 mmHg,进一步治疗3个月后,PaO2仍保持在85 mmHg。本例肝肺综合征是第一例经双甲磺酸丙三嗪持续改善的病例。PaO2升高至少会延缓肝移植。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Oxygenation improvement with almitrine bismesylate in the hepatopulmonary syndrome

A 51 years old male patient was referred for dyspnoea on minimal exertion associated with a severe hypoxemia (PaO2=66 mmHg) and respiratory alkalosis. Investigations led to the diagnosis of hepatopulmonary syndrome. PaO2 increased from 60 to 75 mmHg after one hour of i.v. almitrine bismesylate infusion, and it remained at 85 mmHg after 3 months of further per os treatment. This case of hepatopulmonary syndrome is the first to be persistently improved by almitrine bismesylate. Increase of PaO2 would at least delay the hepatic transplantation.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信